INDIANAPOLIS – The opioid crisis in the U.S. is a growing concern, with over 107,000 people dying from drug overdoses in 2021. The annual economic cost of this crisis exceeds one trillion dollars. However, new research suggests that genetics may play a role in addiction.
A recent study led by Dr. Caroline Freirmuth of the University of Cincinnati ER looked into the genetic factors that could make some people more susceptible to opioid addiction than others. The study involved screening participants in emergency rooms throughout Ohio to identify a potential genetic link to opioid use disorder. By understanding these genetic factors, doctors may be able to tailor opioid prescriptions based on a patient’s genetic makeup to prevent addiction.
The FDA has also taken steps to address the opioid crisis by approving the first over-the-counter drug, naloxone nasal spray, to help reduce drug overdose deaths. Naloxone is a lifesaving emergency treatment that can reverse opioid overdoses and is now available for use without medical training.
This research and the introduction of naloxone nasal spray offer hope in the fight against the opioid crisis. By understanding the genetic factors that contribute to opioid addiction and having access to life-saving treatments, there is potential to save lives and reduce the devastating impact of addiction in our communities.
Source
Photo credit www.wishtv.com
